An open-label, single arm, phase II study of IV weekly (days 1 and 8) topotecan in combination with carboplatin (day 1) every 21 days as second-line therapy in subjects with platinum-sensitive relapsed ovarian cancer: First stage results

Journal article

Peer reviewed

P. E. Schwartz, P. G. Rose, B. J. Monk, D. Provencher, B. Dharan, P. Legenne and L. J. Sherman

Journal of clinical oncology, Vol.26(15_suppl), pp.16518-16518

05/20/2008

Abstract

Abstract only

1 Record Views

Title: An open-label, single arm, phase II study of IV weekly (days 1 and 8) topotecan in combination with carboplatin (day 1) every 21 days as second-line therapy in subjects with platinum-sensitive relapsed ovarian cancer: First stage results
Creators: P. E. Schwartz
P. G. Rose
B. J. Monk
D. Provencher
B. Dharan
P. Legenne
L. J. Sherman
Publication Details: Journal of clinical oncology, Vol.26(15_suppl), pp.16518-16518
Identifiers: 991005969059102656
Academic Unit: Obstetrics & Gynecology
Language: English
Resource Type: Journal article